BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34087787)

  • 1. The modified frailty index and patient outcomes following transforaminal lumbar interbody fusion surgery for single-level degenerative spine disease.
    Moses ZB; Oh SY; Fontes RBV; Deutsch H; O'Toole JE; Fessler RG
    J Neurosurg Spine; 2021 Jun; 35(2):163-169. PubMed ID: 34087787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified Frailty Index Does Not Provide Additional Value in Predicting Outcomes in Patients Undergoing Elective Transforaminal Lumbar Interbody Fusion.
    Tran KS; Lambrechts MJ; Issa TZ; Tecce E; Corr A; Toci GR; Wong A; DiMaria S; Kirkpatrick Q; Chu J; Gilmore G; Kurd MF; Rihn JA; Woods BI; Kaye ID; Canseco JA; Hilibrand AS; Kepler CK; Vaccaro AR; Schroeder GD
    World Neurosurg; 2023 Feb; 170():e283-e291. PubMed ID: 36356842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5-Factor Modified Frailty Index is Associated With Increased Risk of Reoperations and Adjacent Level Disease Following Single-Level Transforaminal Lumbar Interbody Fusion.
    Patel N; Coban D; Changoor S; Sinha K; Hwang KS; Emami A
    Global Spine J; 2023 Aug; ():21925682231196828. PubMed ID: 37596811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frailty is associated with morbidity in adults undergoing elective anterior lumbar interbody fusion (ALIF) surgery.
    Phan K; Kim JS; Lee NJ; Somani S; Di Capua J; Kothari P; Leven D; Cho SK
    Spine J; 2017 Apr; 17(4):538-544. PubMed ID: 27989724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified-frailty index does not independently predict complications, hospital length of stay or 30-day readmission rates following posterior lumbar decompression and fusion for spondylolisthesis.
    Elsamadicy AA; Freedman IG; Koo AB; David WB; Reeves BC; Havlik J; Pennington Z; Kolb L; Shin JH; Sciubba DM
    Spine J; 2021 Nov; 21(11):1812-1821. PubMed ID: 34010683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient Frailty Influences Outcome After Open, But Not Minimally Invasive, Transforaminal Interbody Fusion: A Case Series of 115 Patients With Lumbar Degenerative Disease.
    Burke JF; Garcia JH; Safaee MM; Wong C; Gill SA; Chou D; Mummaneni PV; Deviren V; Ames CP; Clark AJ
    Oper Neurosurg (Hagerstown); 2023 Jun; 24(6):565-571. PubMed ID: 36897093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline Frailty and Discharge to Advanced Care Facilities in Patients Undergoing Lumbar Interbody Fusion for Lumbar Degenerative Disease: A Multicenter Registry Analysis of 7153 Patient Cases Comparing the Risk Analysis Index to the 5-Factor Modified Frailty Index.
    Kassicieh AJ; Marquez J; Skandalakis GP; Rumalla K; Kazim SF; Schmidt MH; Bowers CA
    World Neurosurg; 2023 Dec; 180():e77-e83. PubMed ID: 37574193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frailty and Sarcopenia: Impact on Outcomes Following Elective Degenerative Lumbar Spine Surgery.
    Chotai S; Gupta R; Pennings JS; Hymel AM; Archer KR; Zuckerman SL; Stephens BF; Abtahi AM
    Spine (Phila Pa 1976); 2022 Oct; 47(20):1410-1417. PubMed ID: 35867606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective comparison of radiographic and clinical outcomes in single-level degenerative lumbar disease undergoing anterior versus transforaminal lumbar interbody fusion.
    Moses ZB; Razvi S; Oh SY; Platt A; Keegan KC; Hamati F; Witiw C; David BT; Fontes RBV; Deutsch H; O'Toole JE; Fessler RG
    J Spine Surg; 2021 Jun; 7(2):170-180. PubMed ID: 34296029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 5-factor modified frailty index (mFI-5) predicts adverse outcomes after elective anterior cervical discectomy and fusion (ACDF).
    Chung MS; Patel N; Abdelmalek G; Coban D; Changoor S; Elali F; Sinha K; Hwang K; Emami A
    N Am Spine Soc J; 2024 Jun; 18():100318. PubMed ID: 38618000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of safety and efficacy of posterior lumbar interbody fusion (PLIF) and modified transforaminal lumbar interbody fusion (M-TLIF) in the treatment of single-segment lumbar degenerative diseases.
    Chen M; Cui J; Liu Y; Cai Z; Yang C; Liu H; Chen Y; Yao Z
    J Orthop Surg Res; 2024 Jan; 19(1):95. PubMed ID: 38287376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally invasive transforaminal lumbar interbody fusion using the biportal endoscopic techniques versus microscopic tubular technique.
    Kang MS; You KH; Choi JY; Heo DH; Chung HJ; Park HJ
    Spine J; 2021 Dec; 21(12):2066-2077. PubMed ID: 34171465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Clinical Evaluation of Percutaneous Full-endoscopic Transforaminal Lumbar Interbody Fusion with Pedicle Screw Insertion for Treating Degenerative Lumbar Spinal Stenosis.
    Zhao XB; Ma HJ; Geng B; Zhou HG; Xia YY
    Orthop Surg; 2021 Feb; 13(1):328-337. PubMed ID: 33426744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of transforaminal lumbar interbody fusion in patients with spinal stenosis and degenerative scoliosis.
    Kurra S; Lavelle WF; Silverstein MP; Savage JW; Orr RD
    Spine J; 2018 Jun; 18(6):1014-1021. PubMed ID: 29174460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frailty and sarcopenia do not predict adverse events in an elderly population undergoing non-complex primary elective surgery for degenerative conditions of the lumbar spine.
    Charest-Morin R; Street J; Zhang H; Roughead T; Ailon T; Boyd M; Dvorak M; Kwon B; Paquette S; Dea N; Fisher CG; Flexman AM
    Spine J; 2018 Feb; 18(2):245-254. PubMed ID: 28709946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study on effectiveness of modified-transforaminal lumbar interbody fusion and posterior lumbar interbody fusion surgery in treatment of mild to moderate lumbar spondylolisthesis in middle-aged and elderly patients].
    Yang Z; Liu B; Lan H; Ye H; Chen J; Xia H; Zhang Y; Han F
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2020 May; 34(5):550-556. PubMed ID: 32410419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Outcomes of Minimally Invasive Transforaminal Lumbar Interbody Fusion and Endoscopic Transforaminal Lumbar Interbody Fusion for Lumbar Degenerative Diseases: A Retrospective Matched Case-Control Study.
    Shi L; Ding T; Shi Y; Wang F; Wu C
    World Neurosurg; 2022 Nov; 167():e1231-e1240. PubMed ID: 36096389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of minimally invasive transforaminal lumbar interbody fusion and decompression alone for degenerative lumbar spondylolisthesis.
    Chan AK; Bisson EF; Bydon M; Glassman SD; Foley KT; Potts EA; Shaffrey CI; Shaffrey ME; Coric D; Knightly JJ; Park P; Wang MY; Fu KM; Slotkin JR; Asher AL; Virk MS; Kerezoudis P; Alvi MA; Guan J; Haid RW; Mummaneni PV
    Neurosurg Focus; 2019 May; 46(5):E13. PubMed ID: 31042655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of clinical effect and muscle injury imaging between oblique lateral lumbar interbody fusion and transforaminal lumbar interbody fusion in the treatment of single-segment degenerative lumbar spinal stenosis].
    Li SB; Mei SQ; Xu WB; Fang XQ; Fan SW; Huang LB
    Zhongguo Gu Shang; 2023 May; 36(5):420-7. PubMed ID: 37211932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical comparison of unilateral biportal endoscopic transforaminal lumbar interbody fusion verse 3D microscope-assisted transforaminal lumbar interbody fusion in the treatment of single-segment lumbar spondylolisthesis with lumbar spinal stenosis: a retrospective study with 24-month follow-up.
    Guo W; Li T; Feng C; Yu Y; Hu Y; Fan X
    J Orthop Surg Res; 2023 Dec; 18(1):943. PubMed ID: 38066527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.